Webinar

Optimising Management of Lung Carcinoids: Early vs. Advanced Disease

A Case-Based Multidisciplinary Discussion

Designed for participants with an intermediate level of experience in neuroendocrine neoplasms, this ENETS webinar explores key clinical decision points in the management of lung carcinoids across both early-stage and advanced disease.

Built around two clinical case scenarios, the programme combines case presentations with interactive multidisciplinary panel discussions, focusing on practical challenges in diagnosis and treatment planning in real-world settings.

Educational Level:

Intermediate

Keywords:

LNET, lung carcinoid, treatment, metastatic, early stage

Downloads:

MASTER_29APR26.pdf

Agenda:

Moderator: Anna KOUMARIANOU (GRE)

18:00 – 18:05 Opening comments – Anna KOUMARIANOU (GRE)

18:05 – 18:15 Case presentation 1: Early-stage – Luca BERTOLACCINI (ITA)

18:15 – 18:30 Multidisciplinary panel discussion

- - - Luca BERTOLACCINI (ITA)
    - Jules DERKS (NED)
    - Anna KOUMARIANOU (GRE)
    - Christophe DEROOSE (BEL)
    - Dimitrios FILIPPIADIS (GRE)

18:30 – 18:45 Case presentation 2: Advanced / metastatic case – Jules DERKS (NED)

18:45 – 19:00 Multidisciplinary panel discussion

19:00 – 19:10 Closing comments – Anna KOUMARIANOU (GRE)

Moderators:

Speakers:

The webinar series is intended for HCPs qualified by law to prescribe medicine.

Conflict of Interest Disclosure

In line with EACCME^® standards, all faculty participating in this webinar have disclosed any potential conflicts of interest. The disclosures are available to all participants before and during the webinar session.

Anna KOUMARIANOU (moderator) reports the following potential conflicts of interest:
- Receipt of grants/research supports: SERVIER
- Receipt of honoraria or consultation fees: ASTRA ZENECA
- Participation in a company sponsored speaker's bureau: IPSEN.
Luca BERTOLACCINI (speaker) has no potential conflict of interest to report.
Jules DERKS (speaker) reports the following potential conflicts of interest:
- Receipt of honoraria or consultation fees: IPSEN.
Christophe DEROOSE (speaker) reports the following potential conflicts of interest:
- Receipt of grants/research supports: His institution has received travel fees from GE Healthcare, Sirtex, Ipsen.
- Receipt of honoraria or consultation fees: He is/has been a consultant for (fees received by institution): Sirtex, Advanced Accelerator Applications, Novartis, Ipsen, IRE, Terumo, PSI CRO, Immedica Pharma, Molecular Partners, Nuclear Research and consultancy, Telix and ITM.
- Other support (please specify): CMD is an employee of UZ Leuven.
Dimitrios FILIPPIADIS (speaker) has no potential conflict of interest to report.

UEMS-EACCME^® Accreditation Statement

The ENETS webinar: Optimising Management of Lung Carcinoids: Early vs. Advanced Disease – A Case-Based Multidisciplinary Discussion, Virtual, Germany 29/04/2026 - 29/04/2026, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME^®) with 1.0 European CME credits (ECMEC^®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME^® credits to an equivalent number of AMA PRA Category 1 Credits^TM. Information on the process to convert EACCME^® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME^® for ECMEC^®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Back to webinar archive